These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 10112744)
1. Drug detailing in the hospital: background for policy development. Chan J; Einarson T Can J Hosp Pharm; 1991 Jun; 44(3):161-6. PubMed ID: 10112744 [No Abstract] [Full Text] [Related]
2. Minimizing the influence of drug marketing. Hester FG Hospitals; 1990 Aug; 64(15):80. PubMed ID: 2373503 [No Abstract] [Full Text] [Related]
3. Policy and procedure manual. Medical service representatives. Curr Concepts Hosp Pharm Manage; 1987; 9(2):19-20. PubMed ID: 10282080 [No Abstract] [Full Text] [Related]
4. Guidelines for pharmacists and the pharmaceutical industry. The Canadian Society of Hospital Pharmacists. Dimens Health Serv; 1990 Nov; 67(8):14-6. PubMed ID: 2276520 [No Abstract] [Full Text] [Related]
5. Hospital pharmacists seek to control sales rep activities. Alt SJ Hosp Mater Manage; 1992 Apr; 17(4):2, 16. PubMed ID: 10170987 [No Abstract] [Full Text] [Related]
7. Medicine's "gray market"': why alarm bells are ringing. Gest T; Lanier LK US News World Rep; 1985 Dec; 99(23):52. PubMed ID: 10274713 [No Abstract] [Full Text] [Related]
8. Quality of drug information service provided by pharmaceutical manufacturers. Doyal LE Am J Hosp Pharm; 1990 May; 47(5):1014. PubMed ID: 2337090 [No Abstract] [Full Text] [Related]
9. Dispensing drug samples from the emergency room; drug use evaluation requirements. Rich DS Hosp Pharm; 1994 Nov; 29(11):1042, 1044. PubMed ID: 10138579 [No Abstract] [Full Text] [Related]
13. Drug diversion by hospitals. Provost GP Am J Hosp Pharm; 1968 Apr; 25(4):159. PubMed ID: 5655783 [No Abstract] [Full Text] [Related]
14. Alternative to counter-detailing. Roberts RW; Oliver JA Am J Hosp Pharm; 1979 Oct; 36(10):1308, 1312. PubMed ID: 507067 [No Abstract] [Full Text] [Related]
15. Understanding the resources and organization of an industry-based drug information service. Colvin CL Am J Hosp Pharm; 1990 Sep; 47(9):1989-90. PubMed ID: 2220847 [No Abstract] [Full Text] [Related]
16. Ethical concerns arising from industry/practitioner relationship. Hall K Can J Hosp Pharm; 1987 Apr; 40(2):73-4. PubMed ID: 10282092 [No Abstract] [Full Text] [Related]
17. Improving drug use through purchase agreement commitments. Keys P; Stierer RC; Sterchele JA; Tarasovic CF; Horner LB Am J Hosp Pharm; 1993 Jul; 50(7):1423-4. PubMed ID: 8362877 [No Abstract] [Full Text] [Related]
18. The Canadians are killing us. Struble RA Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58-9. PubMed ID: 12592981 [No Abstract] [Full Text] [Related]
19. A drug problem reporting system for Canadian hospital pharmacies. Friedel H; Gibson C Can J Hosp Pharm; 1978; 31(6):205-6. PubMed ID: 10240006 [No Abstract] [Full Text] [Related]
20. Information responsibilities of generic drug companies. Cramer R Am J Hosp Pharm; 1986 Jul; 43(7):1674, 1679. PubMed ID: 3752098 [No Abstract] [Full Text] [Related] [Next] [New Search]